PDF(Pubmed)
Abstract：
Consumption of legumes and pulses is associated with various health outcomes. Therefore, when updating the Nordic Nutrition Recommendations (NNR), summarizing the best available evidence on key health outcomes regarded as relevant for the Nordic and Baltics related to the consumption of legumes was essential. The aim of this scoping review was to evaluate the updated evidence on the effect of the consumption of legumes and pulses on various health outcomes, as well as their dose-response relationship in updated systematic reviews and meta-analyses. The scoping review is built on a de novo systematic review published in 2023 and additional searches on the consumption of legumes and pulses and its various health outcomes, including cardiovascular disease (CVD), cancer, type 2 diabetes, and obesity. Current available evidence shows that the consumption of legumes and pulses is associated with a lower risk of several cancers (evidence: low-moderate), and lower all-cause mortality (evidence: moderate). The associations with CVDs are neutral or inverse, with studies generally showing favourable changes in biomarkers for CVDs. Legume consumption is associated with a lower risk of obesity (evidence: low). For type 2 diabetes, no association was found with incidence, but trials on consumption of legumes and pulses and biomarkers generally indicated protective effects. Overall, the current evidence supports dietary recommendations to increase the consumption of legumes and pulses.
摘要：
豆类和豆类的消费与各种健康结果有关。因此,在更新北欧营养建议(NNR)时，总结与豆类消费相关的北欧和波罗的海相关的关键健康结果的最佳可用证据至关重要。这项范围界定审查的目的是评估有关食用豆类和豆类对各种健康结果的影响的最新证据，以及它们在更新的系统评价和荟萃分析中的剂量-反应关系。范围审查是建立在2023年发布的从头系统审查以及对豆类和豆类的消费及其各种健康结果的额外搜索之上的。包括心血管疾病（CVD），癌症,2型糖尿病,和肥胖。现有证据表明，豆类和豆类的消费与几种癌症的风险较低有关（证据：低-中度），和较低的全因死亡率（证据：中度）。与CVD的关联是中性或反向的，研究表明，心血管疾病的生物标志物发生了有利的变化。豆类消费与较低的肥胖风险相关（证据：低）。对于2型糖尿病，没有发现与发病率有关联，但是关于豆类、豆类和生物标志物消费的试验通常表明有保护作用。总的来说,目前的证据支持增加豆类和豆类消费的饮食建议。
